SpyGlass Pharma News and Activities

SpyGlass Pharma is a company listed under the stock ticker SGP (US).

Acquisition, funding and merger involving SpyGlass Pharma.

• SpyGlass Pharma is now listed under ticker SGP. (posted on February 6 2026).
• SpyGlass Pharma has filed its IPO. Its stock ticker will be SGP. (posted on January 22 2026).

View the org chart displaying its 20 main executives

Most searched biographies at SpyGlass Pharma

• Patrick Mooney, Chief Executive Officer
• Elizabeth Ofarrell, Director
• Kirk Nielsen, Director

Popular executive movements at SpyGlass Pharma

• Mike Pinder has joined the company as Vice President, Marketing  (posted on June 2 2026).

Create your alert
to follow the executive moves at SpyGlass Pharma.

SpyGlass Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by SpyGlass Pharma

Social media about SpyGlass Pharma

• SpyGlass Pharma on Wikipedia, Google News & Yahoo Finance
• SpyGlass Pharma on LinkedIn, X (Twitter) & YouTube